NCT01049438View on ClinicalTrials.gov

A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Methicillin Resistant Staphylococcus Aureus Skin Infections
Interventions
DRUG

nasal mupirocin

twice daily for 10 days

DRUG

topical 3% hexachlorophene body wash

daily for 10 days

DRUG

oral anti-MRSA antibiotic

The choice of oral antibiotic was based on investigators choice and antibiotic susceptibility of prior MRSA isolates in a given patient

All Listed Sponsors
lead

Natividad Medical Center

OTHER

NCT01049438 - A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections | Biotech Hunter | Biotech Hunter